ACON Aclarion Inc
1,976
$0.334
$0.024
(7.74%)
| Watchers | 1,976 |
| 52-Wk Low | $0.2668 |
| 52-Wk High | $25.60 |
| Market Cap | $2.74M |
| Volume | 8,470.00 |
| 52-Wk High | $25.60 |
| 52-Wk Low | $0.2668 |
Aclarion, Inc. (NASDAQ:ACON) Sees Large Increase in Short InterestZolmax • 2 months ago
Aclarion, Inc. (NASDAQ:ACON Get Free Report) saw a significant growth in short interest during the month of February. As of February 29th, there was short interest totalling 159,100 shares...
Share to Feed
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Confirms predictive value of Nociscan for identifying painful discs. Nociscan demonstrated a sensitivity of 100% and a specificity of 80% compared to provocative discography (PD), suggesting...
BROOMFIELD, CO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire - Aclarion, Inc. ( Aclarion or the Company ) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging...
BROOMFIELD, CO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aclarion, Inc. ( Aclarion or the Company ) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging...
Company is initiating its pivotal multicenter, prospective, randomized CLARITY trial to build on clinical evidence demonstrating superior surgical outcomes when Nociscan is utilized in surgical...
Dr. Uribe is Chief of the Division of Spinal Disorders, Volker K. H. Sonntag Chair of Spine Research, and Vice Chairman of Neurosurgery at Barrow Neurological Institute Dr. Uribe Becomes...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Nociscan is the first augmented intelligence platform to measure pain biomarkers in the lumbar spine This new product release expands accessibility of Nociscan on the worldwide MR market Builds...